Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nexavar receives final appraisal for primary liver cancer

europeanpharmaceuticalreviewAugust 11, 2017

Tag: Nexavar , Liver cancer

PharmaSources Customer Service